Clinical trials
Phase 3 Triple Negative Breast Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 6 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 6 |
| 2025 | 6 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
| Completed | 9 |
| Active, not recruiting | 8 |
| Terminated | 5 |
| Unknown status | 5 |
| Not yet recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 10 |
| Hoffmann-La Roche | 3 |
| Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 3 |
| Chinese Academy of Medical Sciences | 2 |
| Jiangsu HengRui Medicine Co., Ltd. | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 2 |
| Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2 |
| Sun Yat-sen University | 2 |
| Akeso | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 48 |
| Breast Neoplasms | 13 |
| Neoplasm Metastasis | 1 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.